Provided by Tiger Fintech (Singapore) Pte. Ltd.

Castle Biosciences, Inc.

18.54
-0.7300-3.79%
Post-market: 18.540.00000.00%19:14 EDT
Volume:581.56K
Turnover:10.76M
Market Cap:535.29M
PE:-100.50
High:19.36
Open:19.12
Low:18.08
Close:19.27
Loading ...
Oct 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 13, 2024

Correspondence

Form CORRESP - Correspondence
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 27, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]